Cargando…

Gender‐based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient‐level pooled data of six randomized controlled trials

AIMS: To determine the impact of gender on glycaemic control and hypoglycaemia in insulin‐naïve patients with type 2 diabetes (T2DM). METHODS: Data were pooled from six randomized clinical trials of insulin glargine or NPH insulin in insulin‐naïve, inadequately controlled patients. Female [n = 1251;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kautzky‐Willer, A., Kosi, L., Lin, J., Mihaljevic, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680342/ https://www.ncbi.nlm.nih.gov/pubmed/25678212 http://dx.doi.org/10.1111/dom.12449

Ejemplares similares

Early hypoglycaemia and hyperglycaemia and 'tight' glycaemic control with and without glucose infusions
por: Raobaikady, R, et al.
Publicado: (2004)

Prevalence of Hypoglycaemia among Insulin-Treated Pregnant Women with Diabetes Who Achieved Tight Glycaemic Control
por: Ng, Danish, et al.
Publicado: (2019)

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
por: Mauricio, Dídac, et al.
Publicado: (2017)

Hypoglycaemia Remains the Key Obstacle to Optimal Glycaemic Control – Continuous Glucose Monitoring is the Solution
por: Adolfsson, Peter, et al.
Publicado: (2018)

The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability
por: Waeschle, Reiner M, et al.
Publicado: (2008)

An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia
por: Fonseca, V, et al.
Publicado: (2011)

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
por: Renard, Eric, et al.
Publicado: (2021)

Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes
por: Bahrami, Jasmine, et al.
Publicado: (2022)

The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus
por: McEwan, Phil, et al.
Publicado: (2016)

Effect of intensive glycaemic control on moderate hypoglycaemia and ICU length of stay in severe traumatic brain injury
por: Núñez-Patiño, Rafael A., et al.
Publicado: (2018)

Insulin glargine/lixisenatide fixed‐ratio combination improves glycaemic variability and control without increasing hypoglycaemia
por: Aronson, Ronnie, et al.
Publicado: (2018)

Severe neonatal hypoglycaemia and intrapartum glycaemic control in pregnancies complicated by type 1, type 2 and gestational diabetes
por: Yamamoto, J. M., et al.
Publicado: (2019)

Elevated brain glutamate levels in type 1 diabetes: correlations with glycaemic control and age of disease onset but not with hypoglycaemia awareness status
por: Wiegers, Evita C., et al.
Publicado: (2019)

Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24‐week, prospective, randomized, placebo‐controlled pilot trial
por: Harreiter, Jürgen, et al.
Publicado: (2021)

Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients
por: Harreiter, Jürgen, et al.
Publicado: (2017)

Factors influencing glycaemic stability after neonatal hypoglycaemia and relationship to neurodevelopmental outcome
por: Burakevych, Nataliia, et al.
Publicado: (2019)

Betatrophin is downregulated in pregnant women with a history of RYGB operation and a high risk of postprandial hypoglycaemia
por: Leutner, Michael, et al.
Publicado: (2020)

Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials
por: Rosenstock, Julio, et al.
Publicado: (2016)

Does diabetes mellitus mitigate the gender gap in COVID-19 mortality?
por: Kautzky-Willer, Alexandra
Publicado: (2021)

Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study
por: Bajaj, M, et al.
Publicado: (2014)

Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men
por: Deischinger, Carola, et al.
Publicado: (2020)

Sex and Gender Differences in Prevention of Type 2 Diabetes
por: Harreiter, Jürgen, et al.
Publicado: (2018)

Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme
por: DeVries, J. Hans, et al.
Publicado: (2018)

Glycaemic control in diabetic patients in Zambia
por: Musenge, Emmanuel Mwila, et al.
Publicado: (2014)

SUN-048 Cardiometabolic Effects of Cross-Sex Hormone Therapy in Transgender Patients
por: Trebotic, Lana Kosi, et al.
Publicado: (2020)

GlucoTab‐guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes
por: Aberer, Felix, et al.
Publicado: (2018)

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
por: Zinman, Bernard, et al.
Publicado: (2017)

Correlations between parameters of glycaemic variability and foetal growth, neonatal hypoglycaemia and hyperbilirubinemia in women with gestational diabetes
por: Blasi, Immacolata, et al.
Publicado: (2023)

Diabetic patients’ perspectives on the challenges of glycaemic control
por: Adeniyi, Oladele V., et al.
Publicado: (2015)

Editorial: Sex and Gender Aspects in Diabetes
por: Kautzky-Willer, Alexandra, et al.
Publicado: (2019)

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment
por: Javier Escalada, F., et al.
Publicado: (2018)

Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals
por: Tripyla, Afroditi, et al.
Publicado: (2023)

Cardiovascular health through a sex and gender lens in six South Asian countries: Findings from the WHO STEPS surveillance
por: Dev, Rubee, et al.
Publicado: (2022)

Altered glucose profiles and risk for hypoglycaemia during oral glucose tolerance testing in pregnancies after gastric bypass surgery
por: Feichtinger, Michael, et al.
Publicado: (2016)

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass
por: Tharakan, George, et al.
Publicado: (2017)

Switching from Neutral Protamine Hagedorn Insulin to Insulin Glargine 300 U/mL Improves Glycaemic Control and Reduces Hypoglycaemia Risk: Results of a Multicentre, Prospective, Observational Study
por: Wolnik, B., et al.
Publicado: (2020)

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
por: Kautzky-Willer, Alexandra, et al.
Publicado: (2016)

Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL
por: Dailey, George, et al.
Publicado: (2018)

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
por: Bolli, Geremia B., et al.
Publicado: (2021)

Periodontal treatment to improve glycaemic control in diabetic patients: study protocol of the randomized, controlled DIAPERIO trial
por: Vergnes, Jean-Noel, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rj2qhavm9ae17ll87i8rlvfsum